Edition:
United States

People: Bristol-Myers Squibb Co (BMY.N)

BMY.N on New York Stock Exchange

53.55USD
24 Apr 2017
Change (% chg)

$0.07 (+0.13%)
Prev Close
$53.48
Open
$53.93
Day's High
$54.00
Day's Low
$53.51
Volume
1,530,739
Avg. Vol
2,953,826
52-wk High
$77.10
52-wk Low
$46.01

Andreotti, Lamberto 

Mr. Lamberto Andreotti is no longer a Non-Executive Chairman of the Board of Bristol-Myers Squibb Company., effective as of May 2nd, 2017. He has served as Executive Chairman of the Board of the Company from May 5, 2015 to August 3, 2015. He is no longer Chief Executive Officer of the Company effective May 5, 2015. He was Chief Executive Officer, Director of Bristol-Myers Squibb Company. Mr. Andreotti has been Chief Executive Officer since May 2010. He was our President and Chief Operating Officer from March 2009 to May 2010. From March 2008 to March 2009, Mr. Andreotti served as Executive Vice President and Chief Operating Officer of BMS. From May 2007 until March 2008, he served as Executive Vice President of BMS and Chief Operating Officer of Worldwide Pharmaceuticals, a division of BMS. Mr. Andreotti served as Executive Vice President of BMS and President of Worldwide Pharmaceuticals from 2005-2007 and as Senior Vice President and International President of Worldwide Pharmaceuticals from 2002-2005. He is a member of Pharmaceutical Research and Manufacturers of America and The Business Council.

Basic Compensation

Total Annual Compensation, USD 238,015
Restricted Stock Awards, USD 308,015
Long-Term Incentive Plans, USD --
All Other, USD 31,000
Fiscal Year Total, USD 577,030

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 427,500 17,047,100.00